Instil Bio Inc (TIL)

NASDAQ
19.42
+0.02(+0.10%)
  • Volume:
    399,950
  • Bid/Ask:
    18.88/20.00
  • Day's Range:
    19.06 - 19.98

TIL Overview

Prev. Close
19.4
Day's Range
19.06-19.98
Revenue
-
Open
19.54
52 wk Range
14.42-29.49
EPS
-
Volume
399,950
Market Cap
2.5B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
128,743,123
Next Earnings Date
Dec 01, 2021
What is your sentiment on Instil Bio Inc?
or
Market is currently closed. Voting is open during market hours.

Instil Bio Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralStrong BuyStrong BuySell
Technical IndicatorsSellNeutralSellBuyBuy
SummarySellNeutralNeutralStrong BuyNeutral

Instil Bio Inc Company Profile

Instil Bio Inc Company Profile

Sector
Services
Employees
150

Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cell therapy pipeline of autologous tumor infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. It is advancing its lead TIL product candidate, ITIL-168, for the treatment of advanced melanoma. It is also developing a class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR) platform. ITIL-168 is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma. Its pipeline also includes ITIL-306, its lead CoStAR-TIL product candidate. ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (FOLR1), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.